Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA To Industry: Proposed Software Reg Is Not As Bad As You Think

This article was originally published in The Gray Sheet

Executive Summary

The effects of FDA's effort to regulate certain software that interfaces with medical devices may not be as far-reaching as some manufacturers fear, the agency says

You may also be interested in...



Device Data Systems Made Class I; Hospitals Could Face Regulation

FDA last week finalized a three-year-old proposal to down-classify Medical Device Data Systems to class I, or low-risk, medical devices exempt from pre-market review.

Device Data Systems Made Class I; Hospitals Could Face Regulation

FDA last week finalized a three-year-old proposal to down-classify Medical Device Data Systems to class I, or low-risk, medical devices exempt from pre-market review.

Microsoft Enters Debate On FDA Regulation Of Health IT Systems

Software giant Microsoft has joined device trade association AdvaMed in an effort to shape the debate over whether – and to what degree – emerging health information technology should face FDA scrutiny.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026225

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel